Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Sequire Spotlight Presents Zinc 2 Hydrogen, Inc: Fueling the Future w Sustainable Hydrogen Solutions

Host Jon Najarian interviews Director, James Czirr, delving into how Zinc 2 Hydrogen, Inc. is developing the most avant-garde way to manufacture batteries.

Clean Energy
October 26, 2023

Related Videos

Related Posts

Related Videos

Sequire Spotlight Presents uR-eNERGY iNC (URG): Renewable Energy for a Sustainable Tomorrow October 30, 2023
Sequire Spotlight Presents GreenPower: Exploring GreenPower’s Sustainable Energy Solutions October 26, 2023
Sequire Spotlight Presents Society Pass Incorporated (SOPA): A Mix Between Fintech & E-Commerce June 26, 2023
Sequire Spotlight presents Energy Focus Inc. (EFOI): The Future Of Sustainability Is Bright November 10, 2021
Sequire Spotlight Presents: La Rosa Holdings Corp (LRHC) – Providing Tools for Real State Agents November 25, 2024
Sequire Spotlight presents Usio (USIO): Making Payments Simple November 10, 2021
Sequire Spotlight presents Alpha Cognition (ACOGF): Hope For Those Affected By Alzheimers And ALS November 10, 2021
Sequire Spotlight Presents LiveOne, Inc. (LVO): Bringing Music to Your Ears June 17, 2022
Sequire Spotlight Presents Moving iMage Technologies (MITQ): Out-of-Home Entertainment Technologies August 22, 2023
Sequire Spotlight Presents Guerrilla RF (GUER): Making Waves with Radio Frequency Semiconductors September 19, 2022

Related Post

A Growing, Undervalued Opportunity in Solar Installation w/ Actual Profitability

March 10, 2023
Helbiz to Offer On-Demand Taxi Services to Widen International Intermodal Offering

August 11, 2022
OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform

March 15, 2022
Eiger Announces Both Lonafarnib-based Treatments in Pivotal Phase 3 D-LIVR Trial in Hepatitis Delta Virus (HDV) Achieved Statistical Significance Against Placebo in Composite Primary Endpoint

December 8, 2022

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.